Loading ...

Immunosuppresive Medications for Participants in NIS01

(

EXIIST

)

ITN Protocol #:

ITN040CT

Branded Name:

EXIIST

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Type 1 Diabetes

Current Status:

Completed

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

Immunosuppressive Medications for Participants in ITN005CT (EXIIST)

Clinical Operations Manager

NIAID Project Manager

BIG Biostat Analyst

Study Personnel:

Protocol Chair

Daniel Brennan, MD brenan@wudosis.wustl.edu

Work:

314-362-8351

Protocol Chair

Michele DesMarais mdesmarais@immunetolerance.org

Work:

415-353-4406

Protocol Chair

Susan Booher susan.booher@nih.gov

Work:

240-627-3481

Admin Links

Shortcuts

ITN Documents

Links